Publication:
Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women

No Thumbnail Available

Date

2014

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Farvid, Maryam S., Lu Qi, Frank B. Hu, Ichiro Kawachi, Olivia I. Okereke, Laura D. Kubzansky, and Walter C. Willett. 2014. “Phobic Anxiety Symptom Scores and Incidence of Type 2 Diabetes in US Men and Women.” Brain, Behavior, and Immunity 36 (February): 176–82. https://doi.org/10.1016/j.bbi.2013.10.025.

Research Data

Abstract

Context: Emotional stress may be a risk factor for type 2 diabetes (T2D), but the relation between phobic anxiety symptoms and risk of T2D is uncertain. Objective: To evaluate prospectively the association between phobic anxiety symptoms and incident T2D in three cohorts of US men and women. Design, setting and patients: We followed 30,791 men in the Health Professional's Follow-Up Study (HPFS) (1988-2008), 68,904 women in the Nurses' Health Study (NHS) (1988-2008), and 79,960 women in the Nurses' Health Study II (NHS II) (1993-2011). Phobic anxiety symptom scores, as measured by the Crown-Crisp index (CCI), calculated from 8 questions, were administered at baseline and updated in 2004 for NHS, in 2005 for NHS II, and in 2000 for HPFS. Incident T2D was confirmed by a validated supplementary questionnaire. We used Cox proportional hazards analysis to evaluate associations with incident T2D. Results: During 3,099,651 person-years of follow-up, we documented 12,831 incident T2D cases. In multivariate Cox proportional-hazards models with adjustment for major lifestyle and dietary risk factors, the hazard ratios (HRs) of T2D across categories of increasing levels of CCI (scores = 2 to <3, 3 to <4, 4 to <6, 6), compared with a score of <2, were increased significantly by 6%, 10%, 10% and 13% (P-trend = 0.001) for NHS; and by 19%, 11%, 21%, and 29% (P-trend < 0.0001) for NHS II. Each score increment in CCI was associated with 2% higher risk of T2D in NHS (HRs, 1.02, 95% confidence intervals: 1.01-1.03) and 4% higher risk of T2D in NHS II (HRs, 1.04, 95% confidence intervals: 1.02-1.05). Further adjustment for depression did not change the results. In HPFS, the association between CCI and T2D was not significant after adjusting for lifestyle variables. Conclusion: Our results suggest that higher phobic anxiety symptoms are associated with an increased risk of T2D in women.

Description

Other Available Sources

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Open Access Policy Articles (OAP), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories